I have one question on behalf of the committee.
We have a statement issued on April 1, 2005, I think. It's a grant to the Canadian Coordinating Office for Health Technology Assessment, which is actually suggesting that there will be a planned audit and evaluation on the common drug review, a health technology assessment, the Canadian optimal medication prescribing and utilization service, those three or four things. The common drug review is there, supposedly to be issued by the end of June.
Can you tell me about that? This was actually news to the committee up until a short time ago. We were a little surprised that nobody had mentioned that this was happening.